Characteristics and outcome of hospitalized patients with heart failure stratified for chronic kidney disease

被引:0
|
作者
Koenig, Sebastian [1 ,2 ]
Pellissier, Vincent [2 ]
Hohenstein, Sven [2 ]
Leiner, Johannes [1 ,2 ]
Schanner, Carolin [2 ]
Kwast, Stefan [2 ]
Mueller, Marlena [3 ]
Kuhlen, Ralf [4 ]
Bollmann, Andreas [1 ,2 ]
机构
[1] Univ Leipzig, Dept Electrophysiol, Heart Ctr Leipzig, Struempellstr 39, D-04289 Leipzig, Germany
[2] Helios Hlth Inst, Real World Evidence & Hlth Technol Assessment, Berlin, Germany
[3] AstraZeneca, Med Affairs, Hamburg, Germany
[4] Helios Hlth, Berlin, Germany
来源
ESC HEART FAILURE | 2024年 / 11卷 / 05期
关键词
Administrative data; Chronic kidney disease; Heart failure; Heart failure-related device therapy; Hospital readmissions; In-hospital mortality; COMORBIDITIES; MORTALITY; TRENDS;
D O I
10.1002/ehf2.14827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsHeart failure (HF) and chronic kidney disease (CKD) place significant challenges on the healthcare system, and their co-existence is associated with shared adverse outcomes. The multinational CaReMe project was initiated to provide contemporary, real-world epidemiological data on cardiovascular and reno-metabolic diseases. Utilizing data from the German CaReMe cohort, we characterize a multicentric HF population and describe in-hospital outcomes stratified for co-morbid CKD.Methods and resultsThis retrospective, observational study analysed administrative data from inpatient cases hospitalized in 87 German Helios hospitals between 1 January 2016 and 31 August 2022. The first hospitalization of patients aged >= 18 years with a primary discharge diagnosis of HF, based on ICD-10 codes, were considered the index cases, and subsequent hospitalizations were considered as readmissions. Baseline characteristics and outcomes were stratified for co-morbid CKD using ICD-10-encoding from the index cases. Cox regression was utilized for readmission endpoints and in-hospital mortality. In total, 174 829 index cases (mean age 79 +/- 15 years, 49.9% female) were included; of these, 55.0% had coexisting CKD. Patients with CKD were older, suffered from worse HF-related symptoms, had a higher co-morbidity burden, and in-hospital mortality was increased at index and during follow-up. Prevalent CKD was associated with higher rehospitalization rates and was an independent predictor for in-hospital death.ConclusionsWithin this HF inpatient cohort from a multicentric German database, CKD was diagnosed in more than half of the patients and was associated with increased in-hospital mortality at baseline and during follow-up. Rehospitalizations were observed earlier and more frequently in patients with HF and co-morbid CKD.
引用
收藏
页码:2481 / +
页数:977
相关论文
共 50 条
  • [31] Reversibility of chronic heart failure symptoms in chronic kidney disease patients
    Belov, V. V.
    Ilyicheva, O. E.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (01): : 68 - 72
  • [32] Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure
    Katsumata, Mari
    Hirawa, Nobuhito
    Sumida, Koichiro
    Kagimoto, Minako
    Ehara, Yosuke
    Okuyama, Yuki
    Fujita, Megumi
    Fujiwara, Akira
    Kobayashi, Mayumi
    Kobayashi, Yusuke
    Yamamoto, Yuichiro
    Saka, Sanae
    Yatsu, Keisuke
    Fujikawa, Tetsuya
    Toya, Yoshiyuki
    Yasuda, Gen
    Tamura, Kouichi
    Umemura, Satoshi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (05) : 858 - 865
  • [33] Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure
    Mari Katsumata
    Nobuhito Hirawa
    Koichiro Sumida
    Minako Kagimoto
    Yosuke Ehara
    Yuki Okuyama
    Megumi Fujita
    Akira Fujiwara
    Mayumi Kobayashi
    Yusuke Kobayashi
    Yuichiro Yamamoto
    Sanae Saka
    Keisuke Yatsu
    Tetsuya Fujikawa
    Yoshiyuki Toya
    Gen Yasuda
    Kouichi Tamura
    Satoshi Umemura
    Clinical and Experimental Nephrology, 2017, 21 : 858 - 865
  • [34] The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure
    Lainscak, Mitja
    Hodoscek, Lea Majc
    Duengen, Hans-Dirk
    Rauchhaus, Mathias
    Doehner, Wolfram
    Anker, Stefan D.
    von Haehling, Stephan
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (9-10) : 309 - 313
  • [35] Nutrition in chronic heart failure with coexisting chronic kidney disease
    Bennett, Susan J.
    Welch, Janet L.
    Eckert, George J.
    Oldridge, Neil B.
    Murray, Michael D.
    JOURNAL OF CARDIOVASCULAR NURSING, 2006, 21 (01) : 56 - 62
  • [36] Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study
    Melgaard, Line
    Overvad, Thure Filskov
    Skjoth, Flemming
    Christensen, Jeppe Hagstrup
    Larsen, Torben Bjerregaard
    Lip, Gregory Y. H.
    ESC HEART FAILURE, 2018, 5 (02): : 319 - 326
  • [37] Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry
    Canepa, Marco
    Straburzynska-Migaj, Ewa
    Drozdz, Jaroslaw
    Fernandez-Vivancos, Carla
    Garcia Pinilla, Jose Manuel
    Nyolczas, Noemi
    Temporelli, Pier Luigi
    Mebazaa, Alexandre
    Lainscak, Mitja
    Laroche, Cecile
    Maggioni, Aldo Pietro
    Piepoli, Massimo F.
    Coats, Andrew J. S.
    Ferrari, Roberto
    Tavazzi, Luigi
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (01) : 100 - 110
  • [38] The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure
    Mitja Lainscak
    Lea Majc Hodoscek
    Hans-Dirk Düngen
    Mathias Rauchhaus
    Wolfram Doehner
    Stefan D. Anker
    Stephan von Haehling
    Wiener klinische Wochenschrift, 2009, 121 : 309 - 313
  • [39] Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Pitt, Bertram
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Lambelet, Marc
    Lawatscheck, Robert
    Bakris, George L.
    Ruilope, Luis M.
    Agarwal, Rajiv
    JACC-HEART FAILURE, 2022, 10 (11) : 860 - 870
  • [40] Evaluation of the safety and tolerability of spironolactone in patients with heart failure and chronic kidney disease
    Buckallew, Amanda R.
    Tellor, Katie B.
    Watson, Rachel
    Miller, William
    Mbachu, Gina
    Whitlock, Cameron
    Seltzer, Jay R.
    Armbruster, Anastasia L.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (07) : 955 - 960